Agrani Pharmaceutical Private Limited
About Agrani Pharmaceutical Private Limited
Data last updated:
Agrani Pharmaceutical Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24233HR2016PTC058475. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Alok Kumar and Padum Singh.
Its last annual general meeting (AGM) was held on 27 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at SCO No. 30 Sector 11 Panchkula P.S. Sector 5, Haryana, India – 134109.
As per the financials filed for FY 2018, the company reported a revenue of ₹33.78 Lakh, a decline of 13% compared to the previous year. For the same year it recorded a net loss of ₹1.38 Cr (net margin -409.3%) and EBITDA of -₹1.31 Cr (EBITDA margin -388.4%).
As per MCA filings, the company has open charges of ₹5 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Agrani Pharmaceutical Private Limited's registered office is in Panchkula, Haryana.
- Registered AddressSCO No. 30 Sector 11 Panchkula P.S. Sector 5, Haryana, India – 134109
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Agrani Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Agrani Pharmaceutical Private Limited, buy the company report.
Financials of Agrani Pharmaceutical Private Limited
FY 2018 filings availableAgrani Pharmaceutical Private Limited reported revenue of ₹33.78 Lakh (down 13% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 13% in the latest year. EBITDA fell 110% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1.31 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹1.38 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -388.4% | ||
| Net Profit Margin | -409.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Agrani Pharmaceutical Private Limited, buy the company report.
Board of directors of Agrani Pharmaceutical Private Limited
Agrani Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alok Kumar Also directs: Agrani Meals Private Limited, Agrani Homes Real Construction Private Limited, Agrani Homes Private Limited and 2 more | Director | 04 Mar 2016 | 10 Years 7 Months | Current |
| Padum Singh | Director | 04 Mar 2016 | 10 Years 7 Months | Current |
| Rana Ranvir Singh Also directs: Agrani Homes Private Limited | Director | 04 Mar 2016 | 10 Years 7 Months | Current |
| Vijaya Raj Laxmi Also directs: Agrani Meals Private Limited | Director | 04 Mar 2016 | 10 Years 7 Months | Current |
Peer comparison
Agrani Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bam Accounting Services Private Limited | ₹33.79 Lakh (FY 2018) | -63.0% | Delhi, India | |||
| Emerging Minerals Private Limited | ₹33.79 Lakh (FY 2022) | 194.0% | Kolkata, West Bengal, India | |||
| N- Eye Technologies Private Limited | ₹33.79 Lakh (FY 2018) | Ghaziabad, Uttar Pradesh, India | ||||
| Premium Nirman Private Limited | ₹33.79 Lakh (FY 2024) | 9.0% | Kolkata, West Bengal, India | |||
| Emfuel Advantage Private Limited | ₹33.78 Lakh (FY 2024) | 112.0% | Ator Nagla, Uttar Pradesh, India | |||
| Agrani Pharmaceutical Private Limitedthis company | ₹33.78 Lakh (FY 2018) | -₹1.38 Cr | -409.3% | -13.0% | Panchkula, Haryana, India | |
| Sunjames Biotech Private Limited | ₹33.78 Lakh (FY 2024) | 74.0% | Lucknow, Uttar Pradesh, India | |||
| Srilok Industries Private Limited | ₹33.78 Lakh (FY 2024) | -69.0% | Siliguri, West Bengal, India | |||
| Taipan Leather Private Limited | ₹33.78 Lakh (FY 2024) | 79.0% | Chennai, Tamil Nadu, India | |||
| Megapro Star Marketing Private Limited | ₹33.78 Lakh (FY 2019) | 73.0% | Kapurthala, Punjab, India | |||
| Kheda Agrotech Private Limited | ₹33.77 Lakh (FY 2025) | 421.0% | Kota, Rajasthan, India |
To see the full peer comparison of Agrani Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Sep 2016 | 100059671 | Indian Overseas Bank | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Agrani Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Agrani Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Agrani Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Agrani Pharmaceutical Private Limited, buy the company report.
Recent activity
Agrani Pharmaceutical Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Alok Kumar was appointed as Director on 04 Mar 2016.
Frequently asked questions
Agrani Pharmaceutical is an active private limited company based in Panchkula, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 March 2016 (10+ years old) and is registered under CIN U24233HR2016PTC058475.
Agrani Pharmaceutical has 4 current directors:
- Alok Kumar - Director
- Padum Singh - Director
- Rana Ranvir Singh - Director
- Vijaya Raj Laxmi - Director
The latest financial statements of Agrani Pharmaceutical on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 27 September 2018. Year-wise statements from FY 2016 are in the company report.
No. Agrani Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Agrani Pharmaceutical is U24233HR2016PTC058475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Agrani Pharmaceutical was incorporated on 04 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Agrani Pharmaceutical by revenue are Bam Accounting Services Private Limited, Emerging Minerals Private Limited, N- Eye Technologies Private Limited, Premium Nirman Private Limited, Emfuel Advantage Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Alok Kumar was appointed as Director on 04 Mar 2016. Padum Singh was appointed as Director on 04 Mar 2016. Rana Ranvir Singh was appointed as Director on 04 Mar 2016. Agrani Pharmaceutical has 4 board changes on record in total.
The registered office of Agrani Pharmaceutical is at SCO No. 30 Sector 11 Panchkula P.S. Sector 5, Haryana, India – 134109.
Agrani Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Agrani Pharmaceutical has open charges of ₹5 Lakh and no satisfied charges on record as per latest MCA filings.